MARKET

IMCC

IMCC

Im Cannabis Corp
NASDAQ
0.5300
+0.1188
+28.90%
After Hours: 0.5415 +0.0115 +2.17% 19:54 03/28 EDT
OPEN
0.4500
PREV CLOSE
0.4112
HIGH
0.5400
LOW
0.4309
VOLUME
638.69K
TURNOVER
0
52 WEEK HIGH
1.430
52 WEEK LOW
0.1890
MARKET CAP
7.10M
P/E (TTM)
-0.1333
1D
5D
1M
3M
1Y
5Y
IM Cannabis GAAP EPS of -$0.74 misses by $0.30, revenue of $48.8M beats by $13.14M
Earnings News IM Cannabis GAAP EPS of -$0.74 misses by $0.30, revenue of $48.8M beats by $13.14M. IM Cannabis Corp. (IMCC) is expected to report its quarterly results on March 28.
Seeking Alpha · 12h ago
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
IM Cannabis Corp. Reported a 10% year-over-year decrease in revenue to CA$48.8 million for the year ended Dec. 2023. The medical cannabis company has a focus on Israel and Germany. The company's shares traded 7.33% higher on Thursday morning.
Benzinga · 15h ago
IM Cannabis Corp reports results for the quarter ended in December - Earnings Summary
IM Cannabis Corp reports results for the quarter ended in December. Revenue fell 26% to C$10.70 million from a year ago. The company reported a quarterly loss of C$3.29 million. IM Cannabis Corp shares had risen by 23.9% this quarter.
Reuters · 16h ago
IM Cannabis Corp Faces Revenue Decline, Cuts Costs
TipRanks · 16h ago
Earnings Scheduled For March 28, 2024
Universal Stainless is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. Walgreens Boots Alliance is likely to report earnings for its fourth quarter. Companies Reporting Before The Bell include Shimmick and Universal Stainless. Companies reporting after the bell include INmune Bio and Oxford Industries.
Benzinga · 21h ago
Earnings Preview For IM Cannabis
IM Cannabis is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Analysts estimate the company will report an earnings per share of $-0.17. Shares of IM Cannabis were trading at $0.4556 as of March 26.
Benzinga · 1d ago
'GOP Senators Tell DEA To Reject Marijuana Rescheduling, Arguing It Would Violate International Treaties' - Marijuana Moment
Three Republican senators are urging the DEA to reject a marijuana rescheduling recommendation. The senators say the U.S. Should not move cannabis from Schedule I to Schedule III. They say the move would violate international treaty obligations. Supporters and opponents of rescheduled marijuana have made competing arguments.
Benzinga · 1d ago
IM Cannabis Corp <IMCC.CD> expected to post a loss of 17 cents a share - Earnings Preview
IM Cannabis Corp expected to post a loss of 17 cents a share. The company is expected to report a 27.7% decrease in quarterly revenue to C$10.45 million. LSEG's mean analyst estimate for IM Cannabis Corp is for a 17 cents per share loss.
Reuters · 2d ago
More
About IMCC
IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.

Webull offers IM Cannabis Corp stock information, including NASDAQ: IMCC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMCC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMCC stock methods without spending real money on the virtual paper trading platform.